Literature DB >> 6539524

Orchiectomy and chemotherapy with estramustine, cis-platinum, cyclophosphamide, and 5-fluorouracil in newly diagnosed prostate cancer with bone metastases.

S Eisenkraft, R P Huben, J E Pontes.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6539524     DOI: 10.1016/s0090-4295(84)80099-0

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


× No keyword cloud information.
  2 in total

Review 1.  Chemotherapy for prostate cancer. Present concerns and future considerations.

Authors:  G D Chisholm
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 2.  Estramustine phosphate sodium. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in prostate cancer.

Authors:  C M Perry; D McTavish
Journal:  Drugs Aging       Date:  1995-07       Impact factor: 3.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.